


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
SYRE
Spyre Therapeutics Inc.
$31.98
Strengths

Upgraded on attractively valued

Outperform the market
SYRE Price Performance
$29.96 (+6.74%)
$22.85 (+39.96%)
$16.74 (+91.04%)
$17.14 (+86.58%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
SYRE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYRE Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYRE has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 15, 2026
Reiterate
Buy
Wells Fargo
Dec 18, 2025
Initiate
Buy
Citigroup
Dec 18, 2025
Initiate
Outperform
Mizuho
What is SYRE current stock price?
What are SYRE stock strengths?
What is SYRE Risk Level?
What is SYRE market cap and volume?
What is SYRE current Stock IQ?
Should I buy SYRE stock right now?
Is SYRE a Strong Buy right now?
What does a 'Strong Buy' rating mean for SYRE?
What does a 'Strong Sell' rating mean for SYRE?
What factors influence SYRE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
SYRE
Spyre Therapeutics Inc.
Current Price
$31.98

SYRE Price Performance
$29.96 (+6.74%)
$22.85 (+39.96%)
$16.74 (+91.04%)
$17.14 (+86.58%)
SYRE Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Outperform the market
![]()
SYRE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYRE Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYRE has Fair risk level
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 15, 2026
Reiterate
Buy
Wells Fargo
Dec 18, 2025
Initiate
Buy
Citigroup
Dec 18, 2025
Initiate
Outperform
Mizuho
SYRE Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market
SYRE Latest Analysis
Wall Street ish on Spyre Therapeutics Inc. (SYRE) with Strong Buy Rating. Spyre Therapeutics Inc. (NASDAQ:SYRE) is among the 14 best booming stocks to buy right now. On January 5 Wells Fargo reiterated a Buy rating on the stock with a price target of $40. The update follows Mizuhos initiation of coverage on the stock on December 18 with an Outperform rating and a share price target [….]
Thu Jan 15, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
SYRE Stock trends
SYRE Stock performance
SYRE Stock analysis
SYRE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.